InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Malin Life Sciences Holdings Ltd. Officer active across 1 company, notably Poseida Therapeutics, Inc.. Aggregated, 7 reports have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €7.8m. Activity tracked since 16 November 2021. The latest transaction was filed on 8 August 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Malin Life Sciences Holdings Ltd has filed 7 filings in total concerning Poseida Therapeutics, Inc. The 7 sampled filings, from 2021-11-18 to 2025-01-10, are all acquisitions, with EUR 7817423 of buys and EUR 0 of sells.